Whitepapers 28 Apr 2025Function-focused single-cell analysis to accelerate antibody discovery Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies. April 28, 2025 Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 3 Mar 2025R&D trends: Biotech assets & discovery platforms Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D. March 3, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Reports Produced by Inpart 7 Feb 2025Partnering 2030: FME Industries Report Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships. February 7, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Reports Produced by Inpart 7 Jan 2025Partnering 2030: Biopharma Report Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms. January 7, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Reports Produced by Inpart 11 Dec 2024Antibody Therapy R&D trends and breakthrough innovations Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart. December 11, 2024 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Podcast 16 Aug 2024Challenging the European biotech funding status quo Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin. August 16, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 9 Aug 2024Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi. August 9, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 2 Aug 2024Rebroadcast: How does AI assist drug discovery? Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS. August 2, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 24 May 2024How biotech is tackling myasthenia gravis To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion. May 24, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Inside Labiotech 20 May 2024 Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card! We would like to learn more about you. Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card! May 20, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
Reports 16 May 2023Outsourcing in life science R&D today Learn how online platforms facilitate outsourcing in life science R&D. May 16, 2023 Share WhatsApp Twitter Linkedin Email
Reports 14 Feb 2023New frontiers in vaccinology Learn about the latest advances in vaccine technology. February 14, 2023 Share WhatsApp Twitter Linkedin Email